1- (1-CYCLOHEXYL-4-PIPERIDINYL) -1, 3-DIHYDRO-2H-BENZIMIDAZOL-2-ONE DERIVATIVES WHICH HAVE ACTIVITY ON THE M1 RECEPTOR AND THEIR USE IN MEDICINE
Compounds of formula (I) or a salt thereof are provided, wherein R4, R5, R6, Q, R1 and R2 are as defined in the description. Uses of the compounds as medicaments and in the manufacture of medicaments
-
Page/Page column 51
(2008/12/04)
COMPOUNDS WHICH HAVE ACTIVITY AT M1 RECEPTOR AND THEIR USES IN MEDICINE
Compounds of Formula (I) or a salt thereof are provided: wherein R4, R5, R6, Q, R1 and R2 are as defined in the description. Uses of the compounds as medicaments and in the manufacture of medicaments
-
Page/Page column 49-50
(2008/12/04)
1- (1-CYCLOHEXYL-4-PIPERIDINYL) -1, 3-DIHYDRO-2H-BENZIMIDAZOL-2-ONE DERIVATIVES WHICH HAVE ACTIVITY ON THE M1 RECEPTOR AND THEIR USE IN MEDICINE
Compounds of Formula (I) or a salt thereof are provided: wherein R1, R2, R4, R5, R6, Q and Z are as defined in the description. Uses of the compounds as medicaments and in the manufacture of medicamen
-
Page/Page column 54-55
(2008/12/04)
SUBSTITUTED BENZIMIDAZOLONE COMPOUNDS WHICH HAVE ACTIVITY AT M1 RECEPTOR AND THEIR USES IN MEDICINE
Compounds of formula (I) or a salt thereof are provided:(I) wherein R4, R5, R6, Q and n are as defined in the description. Uses of the compounds as medicaments and in the manufacture of medicaments for treating psychotic d
-
Page/Page column 46
(2008/12/04)
COMPOUNDS WHICH HAVE ACTIVITY AT M1 RECEPTOR AND THEIR USES IN MEDICINE
Compounds of Formula (I) or a salt thereof are provided: wherein R4, R5, R6, Q and R1 are as defined in the description. Uses of the compounds as medicaments and in the manufacture of medicaments for treating ps
-
Page/Page column 48
(2008/12/04)
BENZIMIDAZOLES WHICH HAVE ACTIVITY AT M1 RECEPTOR AND THEIR USES IN MEDICINE
Compounds of formula (I), salts and solvates are provided: formula (I), wherein Q, R and R6 are as defined in the claims. Uses of the compounds for therapy, for example in the treatment of psychotic disorders and cognitive impairment, are also disclosed.
-
Page/Page column 118
(2008/06/13)
More Articles about upstream products of 950772-97-1